Nevertheless, much remains to be determined about the precise molecular mechanisms underlying the increased activity of TMEM16A and NKCC1 as well as their interactions with other signaling pathways during hypertension, and most importantly the pathophysiological roles of these molecules in human hypertension. This evidence concerns the gene SLC12A2 and hypertensive disorder.